Table 2.
Physiological and anatomical comparisons between cases and controls
| SIH | REF | P-value | ||
|---|---|---|---|---|
| CSF clearance | ||||
| T1/2, abs (h) | 1.05 ± 0.45 | 4.53 ± 2.92 | 0.04 | |
| Tmax (h) | 2.97 ± 1.36 | 8.02 ± 4.50 | 0.05 | |
| Cmax (µM) | 7.50 ± 3.31 | 3.36 ± 1.64 | 0.01 | |
| Tlag (h) | 0.34 ± 0.39 | 0.46 ± 0.48 | 0.67 | |
| AUC0−∞ (µM h) | 74.71 ± 27.65 | 68.64 ± 7.23 | 0.53 | |
| Volume measures | ||||
| Cerebral cortex (mL) | 501.96 ± 42.20 | 512.33 ± 54.20 | 0.70 | |
| Frontal cortex (mL) | 196.81 ± 20.66 | 203.68 ± 23.17 | 0.53 | |
| Temporal cortex (mL) | 111.03 ± 12.26 | 110.39 ± 12.84 | 0.92 | |
| Parietal cortex (mL) | 137.39 ± 7.31 | 140.77 ± 13.34 | 0.54 | |
| Occipital cortex (mL) | 56.71 ± 6.35 | 57.50 ± 7.70 | 0.82 | |
| Cerebellar cortex (mL) | 107.94 ± 9.65 | 105.04 ± 10.89 | 0.57 | |
| 4th ventricle (mL) | 1.28 ± 0.34 | 1.58 ± 0.29 | 0.067 | |
| 3rd ventricle (mL) | 0.93 ± 0.60 | 0.94 ± 0.32 | 0.93 | |
| Lateral ventricles (mL) | 18.04 ± 12.05 | 19.60 ± 12.04 | 0.79 | |
| Choroid plexus (mL) | 1.29 ± 0.35 | 1.34 ± 0.33 | 0.74 | |
| First time CSF tracer appearance | ||||
| Cisterna magna (min) | 14.50 ± 8.82 | 10.78 ± 5.22 | 0.30 | |
| PVSAS of anterior cerebral artery (A2; min) | 27.00 ± 9.85 | 39.00 ± 20.58 | 0.27 | |
| PVSAS of anterior cerebral artery (distal) | 67.60 ± 45.63 | 72.40 ± 38.85 | 0.86 | |
| PVSAS of middle cerebral artery (M2; min) | 36.20 ± 11.37 | 33.80 ± 20.00 | 0.82 | |
| PVSAS of middle cerebral artery (M3; min) | 80.20 ± 50.45 | 65.60 ± 43.98 | 0.64 | |
| CSF flow measures | ||||
| Net antegrade flow Sylvian aqueduct (mL/min) | 0.75 ± 1.00 | 0.26 ± 0.22 | 0.25 | |
| Net upward flow cranio-cervical junction (mL/min) | 0.98 ± 0.96 | - |
PVSAS: Perivascular subarachnoid space. CSF clearance variables: T1/2, abs: Time (minutes) to 50% of tracer dose absorbed to blood (absorption half-life), indicative of CSF tracer clearance to blood. Tmax: Time (minutes) to maximum concentration. Cmax: Dose-normalized maximum concentration. Tlag: lag-time (minutes) of absorption. AUC0−∞: Dose-normalized area under curve from zero to infinity. Min: Minutes. Continuous variables were compared with independent samples t-test